| First Author | André S | Year | 2023 |
| Journal | J Alzheimers Dis Rep | Volume | 7 |
| Issue | 1 | Pages | 1395-1426 |
| PubMed ID | 38225969 | Mgi Jnum | J:350303 |
| Mgi Id | MGI:7661229 | Doi | 10.3233/ADR-230075 |
| Citation | Andre S, et al. (2023) Modulation of Cytosolic Phospholipase A2 as a Potential Therapeutic Strategy for Alzheimer's Disease. J Alzheimers Dis Rep 7(1):1395-1426 |
| abstractText | BACKGROUND: Alzheimer's disease (AD) is a neurodegenerative disorder lacking any curative treatment up to now. Indeed, actual medication given to the patients alleviates only symptoms. The cytosolic phospholipase A2 (cPLA(2)-IVA) appears as a pivotal player situated at the center of pathological pathways leading to AD and its inhibition could be a promising therapeutic approach. OBJECTIVE: A cPLA(2)-IVA inhibiting peptide was identified in the present work, aiming to develop an original therapeutic strategy. METHODS: We targeted the cPLA(2)-IVA using the phage display technology. The hit peptide PLP25 was first validated in vitro (arachidonic acid dosage [AA], cPLA(2)-IVA cellular translocation) before being tested in vivo. We evaluated spatial memory using the Barnes maze, amyloid deposits by MRI and immunohistochemistry (IHC), and other important biomarkers such as the cPLA(2)-IVA itself, the NMDA receptor, AbetaPP and tau by IHC after i.v. injection in APP/PS1 mice. RESULTS: Showing a high affinity for the C2 domain of this enzyme, the peptide PLP25 exhibited an inhibitory effect on cPLA(2)-IVA activity by blocking its binding to its substrate, resulting in a decreased release of AA. Coupled to a vector peptide (LRPep2) in order to optimize brain access, we showed an improvement of cognitive abilities of APP/PS1 mice, which also exhibited a decreased number of amyloid plaques, a restored expression of cPLA(2)-IVA, and a favorable effect on NMDA receptor expression and tau protein phosphorylation. CONCLUSIONS: cPLA(2)-IVA inhibition through PLP25 peptide could be a promising therapeutic strategy for AD. |
